Overview

A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures

Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
A follow-on, two-year open-label extension study of ganaxolone as add-on therapy in adult patients with drug-resistant partial-onset seizures
Phase:
Phase 3
Details
Lead Sponsor:
Marinus Pharmaceuticals
Treatments:
Ganaxolone
Pregnanolone